Sélectionner la langue
TPBG
TPBG Informations sur la molécule
| Nom anglais | Trophoblast glycoprotein | Nombre de médicaments commercialisés | 0 |
| Nombre de médicaments cliniques | 16 | Alias de la cible | Trophoblast glycoprotein，5T4 oncotrophoblast glycoprotein，5T4，TPBG，5T4 oncofetal antigen，M6P1，5T4 oncofetal trophoblast glycoprotein，Wnt-Activated Inhibitory Factor 1，WAIF1，5T4AG，5T4-AG |
| Phase de R&D la plus avancée | Phase 2 Clinical | ||
| Nom anglais | Trophoblast glycoprotein |
| Alias de la cible | Trophoblast glycoprotein，5T4 oncotrophoblast glycoprotein，5T4，TPBG，5T4 oncofetal antigen，M6P1，5T4 oncofetal trophoblast glycoprotein，Wnt-Activated Inhibitory Factor 1，WAIF1，5T4AG，5T4-AG |
| Nombre de médicaments commercialisés | 0 |
| Nombre de médicaments cliniques | 16 |
| Phase de R&D la plus avancée | Phase 2 Clinical |
TPBG Liste de produits
- Attribut
Protein (10)Cell (1)Antibody (1)
- Bibliothèque de produits
En ligne (12)
- Espèces
Human (6)Cynomolgus / Rhesus macaque (2)Mouse (2)Rat (1)Rabbit (1)
- Étiquette
His Tag & Avi Tag (3)Fc Tag (2)His Tag (4)Fc Tag & Avi Tag (1)- (2)
- Marqueur
Biotin-labeled (3)Unconjugated (8)- (1)
Ajouter au panier
Quantité totale12
- 1
- 2
TPBGAlias de la molécule
TPBG,5T4,M6P1,5T4AG,WAIF1,5T4 oncofetal antigen,Trophoblast glycoprotein,5T4 oncofetal trophoblast glycoprotein
Plateforme de commerce de projets d'anticorps
| Nom du projet | Phase du projet | Type de molécule | Source de molécule | Domain thérapeutique | Indication |
|---|---|---|---|---|---|
| 5T4 mAb - 01 | Lead | Monoclonal | Humanized Mouse | Solid Tumor | Ovarian cancer,Lung cancer |
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Naptumomab estafenatox | TTS-CD3; ABR-217620 | Phase 2 Clinical | Active Biotech Ab | Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Melanoma; Mesothelioma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | Details |
| ALG.APV-527 | ALG.APV 527; ADC-1016; ATOR-1016; ALG.APV-527; ALG-APV-527 | Phase 2 Clinical | Alligator Bioscience Ab, Aptevo Therapeutics Inc | Neoplasms; Solid tumours | Details |
| JK-06 | JK-06 | Phase 2 Clinical | Xinlitai (Chengdu) Biological Technology Co Ltd | Neoplasms; Solid tumours | Details |
| TUB-030 | TUB-030 | Phase 2 Clinical | Tubulis GmbH | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | Details |
| ACR-246 | ACR246; ACR-246; ADC2154; ADC-2154 | Phase 2 Clinical | Hangzhou Adcoris Biopharmacy Co Ltd | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Esophageal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Uterine Cervical Neoplasms | Details |
| IBR-854 | IBR854; IBR-854 | Phase 2 Clinical | Imbioray (Hangzhou) Biomedicine Co Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Solid tumours | Details |
| SYD-1875 | SYD-1875 | Phase 1 Clinical | Synthon Bv | Solid tumours | Details |
| ASN-004 | ASN-004 | Phase 1 Clinical | Asana Biosciences Llc | Solid tumours | Details |
| anti-5T4 CAR NK-cell therapy (Wuxi Peapole's Hospital/Hangzhou Yingbairui Biomedical Technology) | Phase 1 Clinical | Imbioray (Hangzhou) Biomedicine Co Ltd | Solid tumours | Details | |
| Naptumomab estafenatox/Durvalumab | NTX-352 | Phase 1 Clinical | Neotx Therapeutics Ltd | Solid tumours | Details |
| XB-010 | XB-010 | Phase 1 Clinical | Exelixis Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Squamous Cell Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | Details |
| FTL-008.16 | FTL-008.16; FTL008.16 | Phase 1 Clinical | Sound(Chengdu)Biopharmacauticals Co Ltd | Solid tumours | Details |
| CBA-1535 | CBA-1535 | Phase 1 Clinical | Chiome Bioscience Inc | Carcinoma, Non-Small-Cell Lung; Mesothelioma; Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Triple Negative Breast Neoplasms | Details |
| Anti-5T4 CAR-raNK Cell Therapy | Phase 1 Clinical | Imbioray (Hangzhou) Biomedicine Co Ltd | Solid tumours | Details | |
| Prostate cancer vaccine(inactivated viral)(University of Oxford) | Clinical | University Of Oxford | Prostatic Neoplasms | Details | |
| 68Ga-NOTA-H006 | Clinical | Huashan Hospital | Solid tumours | Details |
- Informations sur la molécule
- Liste de produits
- Informations sur les médicaments cliniques
Partager vers :